- Report
- November 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- April 2021
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- August 2022
- 116 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- February 2024
- 150 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- January 2021
- 221 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- December 2024
- 123 Pages
China
From €1718EUR$1,800USD£1,439GBP
- Report
- December 2024
- 267 Pages
China
From €3818EUR$4,000USD£3,199GBP
- Report
- December 2024
- 94 Pages
China
From €1718EUR$1,800USD£1,439GBP
- Report
- March 2024
- 73 Pages
Global
From €3500EUR$3,929USD£3,035GBP
From €123EUR$129USD£103GBP
- Book
- October 2019
- 720 Pages
- Book
- April 2019
- 288 Pages
- Book
- November 2011
- 224 Pages
Aminoglycosides are a class of antibiotics used to treat a wide range of bacterial infections. They are derived from natural sources, such as soil bacteria, and are effective against Gram-negative bacteria. Aminoglycosides work by inhibiting protein synthesis in bacteria, which prevents them from replicating and spreading. They are often used in combination with other antibiotics to treat more serious infections.
Aminoglycosides are commonly used in hospitals and other healthcare settings, as well as in the treatment of serious infections in the community. They are also used in veterinary medicine.
The aminoglycosides market is highly competitive, with a number of companies offering a range of products. Major players in the market include Merck & Co., Pfizer, Sanofi, Novartis, and Bayer. Other companies in the market include Allergan, AstraZeneca, GlaxoSmithKline, and Eli Lilly. Show Less Read more
